Literature DB >> 2423826

Randomised controlled trial of genetic amniocentesis in 4606 low-risk women.

A Tabor, J Philip, M Madsen, J Bang, E B Obel, B Nørgaard-Pedersen.   

Abstract

Outcome of pregnancy after amniocentesis was studied in a randomised controlled trial of 4606 women, age-range 25-34 years, without known risk of genetic disease. Spontaneous abortion rate was 1.7% in the study group after amniocentesis and 0.7% in the control group after ultrasound (relative risk 2.3). In the study group, increased levels of maternal serum alpha-fetoprotein before amniocentesis, perforation of the placenta during amniocentesis, and withdrawal of discoloured amniotic fluid were associated with an increased risk of spontaneous abortion. In the first six weeks after amniocentesis/ultrasound scan, amniotic fluid leakage occurred more often in the study group but there was no difference in the rate of vaginal bleeding. Frequency of postural malformations in the infants in the two groups was the same. In the study group, respiratory distress syndrome was diagnosed more often (relative risk 2.1) and more babies were treated for pneumonia (relative risk 2.5).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423826     DOI: 10.1016/s0140-6736(86)91218-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  85 in total

1.  Amniocentesis and informed consent.

Authors:  Michael Drummond; Louise Knight
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-20

2.  Information and decision support needs of parents considering amniocentesis: interviews with pregnant women and health professionals.

Authors:  Marie-Anne Durand; Mareike Stiel; Jacky Boivin; Glyn Elwyn
Journal:  Health Expect       Date:  2010-06       Impact factor: 3.377

Review 3.  Prenatal diagnosis: the medical genetics perspective. Ethics and Public Policy Committee, Canadian College of Medical Geneticists.

Authors: 
Journal:  CMAJ       Date:  1991-05-01       Impact factor: 8.262

4.  The effects of mid-trimester amniocentesis on lung function in the neonatal period.

Authors:  A D Milner; E W Hoskyns; I E Hopkin
Journal:  Eur J Pediatr       Date:  1992-06       Impact factor: 3.183

Review 5.  Ultrasonographic soft markers of aneuploidy in second trimester: are we lost?

Authors:  Sameer Raniga; P D Desai; Hetal Parikh
Journal:  MedGenMed       Date:  2006-01-11

Review 6.  Amniocentesis and chorionic villus sampling for prenatal diagnosis.

Authors:  Zarko Alfirevic; Kate Navaratnam; Faris Mujezinovic
Journal:  Cochrane Database Syst Rev       Date:  2017-09-04

7.  Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma.

Authors:  Rossa W K Chiu; K C Allen Chan; Yuan Gao; Virginia Y M Lau; Wenli Zheng; Tak Y Leung; Chris H F Foo; Bin Xie; Nancy B Y Tsui; Fiona M F Lun; Benny C Y Zee; Tze K Lau; Charles R Cantor; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

8.  Factors that affect the decision to undergo amniocentesis in women with normal Down syndrome screening results: it is all about the age.

Authors:  Julia Grinshpun-Cohen; Talya Miron-Shatz; Liat Ries-Levavi; Elon Pras
Journal:  Health Expect       Date:  2014-05-12       Impact factor: 3.377

9.  Prenatal diagnosis for paediatricians.

Authors:  Anne Summers
Journal:  Paediatr Child Health       Date:  2003-01       Impact factor: 2.253

Review 10.  Noninvasive prenatal testing: the future is now.

Authors:  Errol R Norwitz; Brynn Levy
Journal:  Rev Obstet Gynecol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.